Clinical Trial Update: Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream [Phase 2]

View source ↗

Summary

This update summarizes the cellular and molecular changes observed during treatment of actinic keratosis with imiquimod 5% cream in a Phase 2 trial that has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED